Author:
Yoshida Chikashi,Kondo Takeshi,Ito Tomoki,Kizaki Masahiro,Yamamoto Kazuhiko,Miyamoto Toshihiro,Morita Yasuyoshi,Eto Tetsuya,Katsuoka Yuna,Takezako Naoki,Uoshima Nobuhiko,Imada Kazunori,Ando Jun,Komeno Takuya,Mori Akio,Ishikawa Yuichi,Satake Atsushi,Watanabe Junichi,Kawakami Yoshiko,Morita Tetsuo,Taneike Ikue,Nakayama Masahiko,Duan Yinghui,Garbayo Guijarro Belen,Delgado Alexander,Llamas Cynthia,Kiyoi Hitoshi
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Hou HA, Tien HF. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies. J Biomed Sci. 2020;27:81.
2. Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11:41.
3. National Cancer Institute. Cancer stat facts: leukemia—acute myeloid leukemia (AML) 2020 [Available from: https://seer.cancer.gov/statfacts/html/amyl.html.
4. Cancer Information Service NCC, Japan. Chronic lymphocytic leukemia/small lymphocytic lymphoma. 2016. Available from: https://ganjoho.jp/public/cancer/CLL/.
5. Yi M, Li A, Zhou L, Chu Q, Song Y, Wu K. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017. J Hematol Oncol. 2020;13:72.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献